Rights and permissions
About this article
Cite this article
Satraplatin + prednisone “shows promise” in hormone-refractory prostate cancer. Inpharma Wkly. 1486, 9 (2005). https://doi.org/10.2165/00128413-200514860-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200514860-00024